Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)
Clinical trial NCT04267393 · TERMINATED
Trial details
- NCT number
- NCT04267393
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-17
- Primary completion
- 2023-08-16
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.